Literature DB >> 25510795

[Giant cystic lymphangioma breast. Report of a case with 20-year follow-up and review of the literature].

Víctor Manuel Vargas-Hernández1, José María Tovar-Rodríguez2, Mario Adán Moreno-Eutimio2, Gustavo Acosta-Altamirano2.   

Abstract

BACKGROUND: Lymphangiomas are congenital malformations or acquired (secondary to trauma, infection or neoplasia) in the mammary gland, are extremely rare. These lesions tend to infiltrate surrounding tissues and malignant degeneration is extremely rare. Clinically manifests as benign masses, slow growing; diagnosed clinically and by imaging studies. Suegery with removal of the mass is performed for aesthetic reasons and to make differential diagnosis with other common injuries. CLINICAL CASE: Women 45 years of age with progressive increase in size of the left breast, breast trauma concerns and has no other symptoms.The histologic diagnosis was cystic lymphangioma giant left mammary gland. DISCUSSION: Lymphangiomas are uncommon lesions and extremely rare in the mammary gland, locally aggresive behavior and are benign, where abnormal lymphatic tissue has some ability to proliferate and accumulate large amounts of liquid, representing cystic appearance, as presented in our case. Local surgical excision is the treatment.
CONCLUSION: In this first case of giant breast cystic lymphangioma reported in Mexico, which corroborates the benignity of the lesion.

Entities:  

Keywords:  Mammary gland; benign breast tumors; glándula mamaria; linfangioma; lymphangioma; tumores benignos de mama

Mesh:

Year:  2014        PMID: 25510795

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  1 in total

Review 1.  Concomitant breast and axillary lymphangioma in an adult: A case report and a review of the literature.

Authors:  Taejin Park; Han Shin Lee; Eun Jung Jung; Ju Yeon Kim; Chi Young Jeong; Young Tae Ju; Young Joon Lee; Soon Chan Hong; Bo Hwa Choi; Hyo Jung An
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.